Skip to main navigation Skip to search Skip to main content

Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine.

  • Guilherme Rabinowits
  • , Daniel Herchenhorn
  • , Milton Rabinowits
  • , Daniel Weatge
  • , Wilhermo Torres

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalAnti-Cancer Drugs
Volume14
DOIs
StatePublished - Jan 9 2003
Externally publishedYes

Disciplines

  • Anesthesiology
  • Medicine and Health Sciences
  • Molecular Biology
  • Endocrinology, Diabetes, and Metabolism

Cite this